🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
313,52 USD
Máx. histórico
322,75
4 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-2,86%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,12%
Cierre anterior
307,02
Rango de hoy
309,46 – 317,76
Volumen hoy
195.564
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 33,04 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 350,92 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 23 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 13/03/1996 | 41,64 | 41,64 | 40,24 | 40,24 | -1,15% | 3,37% | 82.608 |
| 12/03/1996 | 43,04 | 43,04 | 40,70 | 40,70 | -2,25% | 5,43% | 23.217 |
| 11/03/1996 | 42,11 | 43,04 | 41,17 | 41,64 | -2,20% | 4,44% | 68.528 |
| 08/03/1996 | 43,98 | 43,98 | 41,17 | 42,58 | -2,15% | 6,38% | 42.186 |
| 07/03/1996 | 43,04 | 43,98 | 43,04 | 43,51 | +0,00% | 2,17% | 25.354 |
| 06/03/1996 | 43,98 | 43,98 | 43,04 | 43,51 | -1,06% | 2,13% | 24.205 |
| 05/03/1996 | 43,04 | 43,98 | 42,58 | 43,98 | -1,57% | 3,26% | 43.602 |
| 04/03/1996 | 44,45 | 45,38 | 43,98 | 44,68 | -0,52% | 3,16% | 33.850 |
| 01/03/1996 | 44,92 | 46,32 | 44,45 | 44,92 | -1,03% | 4,17% | 26.450 |
| 29/02/1996 | 44,45 | 46,32 | 44,45 | 45,38 | +1,04% | 4,21% | 52.124 |
| 28/02/1996 | 44,92 | 45,85 | 43,04 | 44,92 | +0,00% | 6,25% | 48.678 |
| 27/02/1996 | 44,45 | 45,38 | 43,04 | 44,92 | +0,00% | 5,26% | 59.578 |
| 26/02/1996 | 47,72 | 47,72 | 42,11 | 44,92 | -2,04% | 11,76% | 59.605 |
| 23/02/1996 | 46,79 | 48,19 | 45,85 | 45,85 | -2,97% | 5,00% | 48.464 |
| 22/02/1996 | 48,19 | 48,19 | 46,79 | 47,26 | +0,00% | 2,91% | 30.030 |
| 21/02/1996 | 46,79 | 48,19 | 45,38 | 47,26 | +1,00% | 6,00% | 39.968 |
| 20/02/1996 | 46,79 | 46,79 | 44,92 | 46,79 | +0,00% | 4,00% | 39.835 |
| 16/02/1996 | 44,92 | 47,26 | 44,92 | 46,79 | +4,17% | 5,21% | 78.120 |
| 15/02/1996 | 46,32 | 46,79 | 44,92 | 44,92 | +0,00% | 4,04% | 37.644 |
| 14/02/1996 | 46,79 | 47,72 | 44,92 | 44,92 | -3,03% | 6,00% | 24.953 |
| 13/02/1996 | 43,98 | 46,32 | 42,58 | 46,32 | +4,21% | 8,51% | 66.525 |
| 12/02/1996 | 46,32 | 46,32 | 43,98 | 44,45 | -4,04% | 5,05% | 43.468 |
| 09/02/1996 | 45,85 | 46,79 | 44,92 | 46,32 | +2,06% | 4,08% | 51.804 |
| 08/02/1996 | 47,26 | 47,26 | 43,98 | 45,38 | -1,02% | 6,93% | 34.812 |
| 07/02/1996 | 48,66 | 48,66 | 45,85 | 45,85 | -2,00% | 5,77% | 53.807 |
| 06/02/1996 | 49,59 | 49,59 | 46,32 | 46,79 | -5,66% | 6,60% | 69.784 |
| 05/02/1996 | 48,66 | 49,59 | 47,26 | 49,59 | +1,92% | 4,81% | 32.701 |
| 02/02/1996 | 47,26 | 49,13 | 47,26 | 48,66 | -0,95% | 3,96% | 21.106 |
| 01/02/1996 | 50,06 | 51,47 | 47,26 | 49,13 | -0,94% | 8,41% | 37.190 |
| 31/01/1996 | 49,13 | 51,47 | 47,72 | 49,59 | +1,92% | 7,62% | 72.883 |